Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Fever Due to Malaria With Ibuprofen

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Uncomplicated falciparum malaria~* Asexual parasitaemia between 20,000 and 200,000/µL~* Fever with temperature above 38 °C or history of fever during the preceding 24 hours~* Informed consent~Exclusion Criteria:~* Effective anti-malarial treatment for the present attack~* Antipyretic use within 6 hours of presentation~* Contraindications to the use of ibuprofen (history of asthma, dyspeptic symptoms, gastro-intestinal bleeding, or allergy to ibuprofen)~* Mixed plasmodial infection~* Haemoglobin \< 7 g/dL~* Packed-cell volume \< 20%~* White cell count \> 16,000/L~* Platelet count \< 40,000/µL~* Schizontaemia \> 50/µL~* Impaired consciousness~* Convulsions or history of convulsions~* Concomitant diseases masking assessment of response

- Gender: ALL
- Minimum Age: 2 Years
- Maximum Age: 7 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).